Safety and immunogenicity of a trivalent, inactivated, mammalian cell culture-derived influenza vaccine in healthy adults, seniors, and children

By Halperin S.A.   Smith B.   Mabrouk T.   Germain M.   Trepanier P.   Hassell T.   Treanor J.   Gauthier R.   Mills E.L.  

Vaccine, Vol. 20, Iss. 7, 2002-01 ,pp. : 1240-1247

Elsevier

Access to resources Recommend Favorite

Safety of a trivalent live attenuated intranasal influenza vaccine, FluMist&unknown;, administered in addition to parenteral trivalent inactivated influenza vaccine to seniors with chronic medical conditions

By Jackson L.A.   Holmes S.J.   Mendelman P.M.   Huggins L.   Cho I.   Rhorer J.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1905-1909

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of a new formulation of an inactivated hepatitis A vaccine

By Dagan R.   Greenberg D.   Goldenbertg-Gehtman P.   Vidor E.   Briantais P.   Pinsk V.   Athias O.   Dumas R.  

Vaccine, Vol. 17, Iss. 15, 1999-04 ,pp. : 1919-1925

Elsevier

Access to resources Recommend Favorite

Safety and immunogenicity of an inactivated subunit influenza virus vaccine combined with MF59 adjuvant emulsion in elderly subjects, immunized for three consecutive influenza seasons

By Minutello M.   Senatore F.   Cecchinelli G.   Bianchi M.   Andreani T.   Podda A.   Crovari P.  

Vaccine, Vol. 17, Iss. 2, 1999-01 ,pp. : 99-104

Elsevier

Access to resources Recommend Favorite

Enhancement of the immune response in rabbits to a malaria DNA vaccine by immunization with a needle-free jet device

By Aguiar J.C.   Hedstrom R.C.   Rogers W.O.   Charoenvit Y.   Sacci J.B.   Lanar D.E.   Majam V.F.   Stout R.R.   Hoffman S.L.  

Vaccine, Vol. 20, Iss. 1, 2001-10 ,pp. : 275-280

Elsevier

Access to resources Recommend Favorite